Novo Nordisk A/s

Novo Nordisk Healthcare Ag

Novo Nordisk Pharmaceuticals, Inc.

Jens Aas Jansen

Ole Juul Nordfang

Marie Johannessen

The invention relates to the use of a Factor VIIa for the manufacture of a medicament for treatment of a condition affectable by Factor VIIa, said medicament being for subcutaneous, intramuscular or intradermal administration, and to the use of a Factor VIIa for the manufacture of a medicament for treatment of a condition affectable by Factor VIIa, wherein said medicament, when administered subcutaneously, intradermally or intramuscularly, shows a prolonged biological half-life.

Growing community of inventors

Charlottenlund, Denmark

Jens Aas Jansen